BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11992293)

  • 1. Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis.
    Ma L; Kovacs JA; Cargnel A; Valerio A; Fantoni G; Atzori C
    J Infect Dis; 2002 May; 185(10):1530-2. PubMed ID: 11992293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
    Ma L; Borio L; Masur H; Kovacs JA
    J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumocystis carinii mutations are associated with duration of sulfa or sulfone prophylaxis exposure in AIDS patients.
    Kazanjian P; Armstrong W; Hossler PA; Burman W; Richardson J; Lee CH; Crane L; Katz J; Meshnick SR
    J Infect Dis; 2000 Aug; 182(2):551-7. PubMed ID: 10915088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene.
    Huang L; Beard CB; Creasman J; Levy D; Duchin JS; Lee S; Pieniazek N; Carter JL; del Rio C; Rimland D; Navin TR
    J Infect Dis; 2000 Oct; 182(4):1192-8. PubMed ID: 10979917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid detection of mutations in the human-derived Pneumocystis carinii dihydropteroate synthase gene associated with sulfa resistance.
    Ma L; Kovacs JA
    Antimicrob Agents Chemother; 2001 Mar; 45(3):776-80. PubMed ID: 11181359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
    Ponce CA; Chabé M; George C; Cárdenas A; Durán L; Guerrero J; Bustamante R; Matos O; Huang L; Miller RF; Vargas SL
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.
    Kazanjian P; Locke AB; Hossler PA; Lane BR; Bartlett MS; Smith JW; Cannon M; Meshnick SR
    AIDS; 1998 May; 12(8):873-8. PubMed ID: 9631140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic diversity of drug targets including dihydropteroate synthase, dihydrofolate reductase and cytochrome b, in Pneumocystis carinii f. sp. hominis isolates in Japan.
    Takahashi T; Kanda T; Iwamoto A
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):159-76. PubMed ID: 15080506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients.
    Nahimana A; Rabodonirina M; Zanetti G; Meneau I; Francioli P; Bille J; Hauser PM
    J Infect Dis; 2003 Oct; 188(7):1017-23. PubMed ID: 14513422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of dihydropteroate synthase gene typing for Pneumocystis carinii f.sp. hominis epidemiology.
    Santos LD; Lacube P; Latouche S; Kac G; Mayaud C; Marteau M; Poirot JL; Maury E; Guillot J; Roux P
    J Eukaryot Microbiol; 1999; 46(5):133S-134S. PubMed ID: 10519287
    [No Abstract]   [Full Text] [Related]  

  • 11. Increase in prevalence of Pneumocystis carinii mutations in patients with AIDS and P. carinii pneumonia, in the United States and China.
    Kazanjian PH; Fisk D; Armstrong W; Shulin Q; Liwei H; Ke Z; Meshnick S
    J Infect Dis; 2004 May; 189(9):1684-7. PubMed ID: 15116306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic analysis of multiple loci suggests that mutations in the Pneumocystis carinii f. sp. hominis dihydropteroate synthase gene arose independently in multiple strains.
    Ma L; Kovacs JA
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3213-5. PubMed ID: 11600382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.
    Navin TR; Beard CB; Huang L; del Rio C; Lee S; Pieniazek NJ; Carter JL; Le T; Hightower A; Rimland D
    Lancet; 2001 Aug; 358(9281):545-9. PubMed ID: 11520525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydropteroate synthase (DHPS) gene mutation study in HIV-Infected Indian patients with Pneumocystis jirovecii pneumonia.
    Tyagi AK; Mirdha BR; Luthra K; Guleria R; Mohan A; Singh UB; Samantaray JC; Dar L; Iyer VK; Chaudhry R
    J Infect Dev Ctries; 2010 Nov; 4(11):761-6. PubMed ID: 21252456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy.
    Takahashi T; Hosoya N; Endo T; Nakamura T; Sakashita H; Kimura K; Ohnishi K; Nakamura Y; Iwamoto A
    J Clin Microbiol; 2000 Sep; 38(9):3161-4. PubMed ID: 10970350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.
    Helweg-Larsen J; Benfield TL; Eugen-Olsen J; Lundgren JD; Lundgren B
    Lancet; 1999 Oct; 354(9187):1347-51. PubMed ID: 10533864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumocystis jiroveci dihydropteroate synthase gene mutations among colonized individuals and Pneumocystis pneumonia patients from Spain.
    Friaza V; Morilla R; Respaldiza N; de la Horra C; Calderón EJ
    Postgrad Med; 2010 Nov; 122(6):24-8. PubMed ID: 21084778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of mutations associated with sulfa resistance in Pneumocystis carinii dihydropteroate synthase gene from non-human primates.
    Demanche C; Guillot J; Berthelemy M; Petitt T; Roux P; Wakefield AE
    Med Mycol; 2002 Jun; 40(3):315-8. PubMed ID: 12146763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia.
    Nahimana A; Rabodonirina M; Helweg-Larsen J; Meneau I; Francioli P; Bille J; Hauser PM
    Emerg Infect Dis; 2003 Jul; 9(7):864-7. PubMed ID: 12890330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia.
    Stein CR; Poole C; Kazanjian P; Meshnick SR
    Emerg Infect Dis; 2004 Oct; 10(10):1760-5. PubMed ID: 15504261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.